IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals Intl

CUSIP: 91911K102 | 1287 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Bruce & Co., Inc.124,000
0.2% of portfolio›$611.3K
StyleTurnoverLocationFiled
Bruce & Co., Inc.
124,000$611.3K0.2%ValueVery LowChicago, IL2026-08-14